Showing results 41 to 60 of 69
< previous
next >
Preview | Issue Date | Title | Author(s) |
| 2011 | Mechanisms of Co-operation of DNMT3A Mutations with JAK2 V617F Through Histone H4 Arginine 3 Provides New Insights in MPN Disease Pathogenesis | Rao, N.; Butcher, C.; Neufing, P.; Bray, S.; Hahn, C.; Scott, H.; Vaz de Melo, J.; Ross, D.; Lewis, I.; Bardy, P.; D'Andrea, R.; Annual Meeting and Exposition of the American Society of Hematology (53rd : 2011 : San Diego, California) |
| 2013 | Methylation of KLF5 contributes to reduced expression in acute myeloid leukaemia and is associated with poor overall survival | Diakiw, S.; Perugini, M.; Kok, C.; Engler, G.; Cummings, N.; To, L.; Wei, A.; Lewis, I.; Brown, A.; D'Andrea, R. |
| 2017 | miR-155 as a potential target of IL-3 signaling in primary AML cells | Sadras, T.; Kok, C.; Perugini, M.; Ramshaw, H.; D'Andrea, R. |
| 2000 | Molecular aspects of polycythemia vera (review) | Butcher, C.; D'Andrea, R. |
| 2010 | Molecular basis of cytokine receptor activation | Lopez, A.; Hercus, T.; Ekert, P.; Littler, D.; Guthridge, M.; Thomas, D.; Ramshaw, H.; Stomski, F.; Perugini, M.; D'Andrea, R.; Grimbaldeston, M.; Parker, M. |
| 2001 | Molecular cloning of a human Vent-like homeobox gene | Moretti, P.; Davidson, A.; Baker, E.; Lilley, B.; Zon, L.; D'Andrea, R. |
| 2013 | NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisis | Watkins, D.; Hughes, T.; White, D.; D'Andrea, R. |
| 2014 | Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profiling | Pishas, K.; Neuhaus, S.; Clayer, M.; Schreiber, A.; Lawrence, D.; Perugini, M.; Whitfield, R.; Farshid, G.; Manavis, J.; Chryssidis, S.; Mayo, B.; Haycox, R.; Ho, K.; Brown, M.; D'Andrea, R.; Evdokiou, A.; Thomas, D.; Desai, J.; Callen, D.; Neilsen, P. |
| 2004 | Overlapping motifs in the membrane-proximal region of cytokine receptor accessory and signaling subunits | D'Andrea, R.; Sadlon, T.; Gonda, T. |
| 2012 | p53-dependent transcriptional responses to interleukin-3 signaling | Jabbour, A.; Gordon, L.; Daunt, C.; Green, B.; Kok, C.; D'Andrea, R.; Ekert, P.; Hofmann, T.G. |
| 2001 | Peptide insertions in domain 4 of hbc, the shared signalling receptor subunit for GM-CSF, IL3 and IL5, induce ligand-independent activation | Jones, K.; Bagley, C.; Butcher, C.; Barry, S.; Vadas, M.; D'Andrea, R. |
| 2010 | Pharmacotherapy of chronic immune thrombocytopenic purpura (ITP) with romiplostim | Perugini, M.; Lee, H.; McRae, S.; D'Andrea, R. |
| 2007 | Potential for clinical ex vivo expansion of cord blood haemopoietic stem cells using non-haemopoietic factor supplements | Hutton, J.; D'Andrea, R.; Lewis, I. |
| 2009 | Repression of Gadd45α by activated FLT3 and GM-CSF receptor mutants contributes to growth, survival and blocked differentiation | Perugini, M.; Kok, C.; Brown, A.; Wilkinson, C.; Salerno, D.; Young, S.; Diakiw, S.; Lewis, I.; Gonda, T.; D'Andrea, R. |
| 1997 | Roles of the N and C terminal domains of the interleukin-3 receptor alpha chain in receptor function. | Barry, S.; Korpelainen, E.; Sun, Q.; Stomski, F.; Moretti, P.; Wakao, H.; D'Andrea, R.; Vadas, M.; Lopez, A.; Goodall, G. |
| 2011 | RUNX1 Mutations are rare in chronic phase polycythaemia vera | Butcher, C.; Neufing, P.; Eriksson, L.; Carmichael, C.; Wilkins, E.; Vaz de Melo, J.; Lewis, I.; Bardy, P.; Scott, H.; D'Andrea, R. |
| 2013 | Signalling by the βc family of cytokines | Hercus, T.; Dhagat, U.; Kan, W.; Broughton, S.; Nero, T.; Perugini, M.; Sandow, J.; D'Andrea, R.; Ekert, P.; Hughes, T.; Parker, M.; Lopez, A. |
| 1999 | Simultaneous antagonism of interleukin-5, granulocyte-macrophage colony-stimulting factor, and interleukin-3 stimulation of human eosinophils by targetting the common cytokine binding site of their receptors | Sun, Q.; Jones, K.; McClure, B.; Cambareri, B.; Zacharakis, B.; Iversen, P.; Stomski, F.; Woodcock, J.; Bagley, C.; D'Andrea, R.; Lopez, A. |
| 2002 | Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-a signaling | Xia, P.; Wang, L.; Moretti, P.; Albanese, N.; Chai, F.; Pitson, S.; D'Andrea, R.; Gamble, J.; Vadas, M. |
| 2017 | Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia. | Powell, J.; Lewis, A.; Zhu, W.; Toubia, J.; Pitman, M.; Wallington-Beddoe, C.; Moretti, P.; Iarossi, D.; Samaraweera, S.; Cummings, N.; Ramshaw, H.; Thomas, D.; Wei, A.; Lopez, A.; D'Andrea, R.; Lewis, I.; Pitson, S. |